metanephrine has been researched along with pentagastrin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bastie, D; Caron, P; Chabre, O; Chabrier, G; Conte-Devolx, B; Henry, JF; Lecomte, P; Maes, B; Nguyen, L; Niccoli-Sire, P; Rohmer, V | 1 |
| Belloni, DR; Daniels, GH; Ernesti, MM; Harris, RD; Kinlaw, WB; Maue, RA; Memoli, VA; Noll, WW; Porter, DM; Scott, SM; Spooner, ET | 1 |
2 other study(ies) available for metanephrine and pentagastrin
| Article | Year |
|---|---|
Pheochromocytoma in multiple endocrine neoplasia type 2: a prospective study.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Calcitonin; Carcinoma, Medullary; Catecholamines; Child; Child, Preschool; Drosophila Proteins; Humans; Infant; Magnetic Resonance Imaging; Metanephrine; Multiple Endocrine Neoplasia Type 2a; Multiple Endocrine Neoplasia Type 2b; Mutation; Pentagastrin; Pheochromocytoma; Prospective Studies; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Receptor Protein-Tyrosine Kinases; Thyroid Neoplasms; Tomography, X-Ray Computed | 2001 |
Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma.
Topics: Adolescent; Adult; Calcitonin; Calcium; Carcinoma, Medullary; Catecholamines; Child; Codon; Female; Humans; Male; Metanephrine; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Pedigree; Pentagastrin; Pheochromocytoma; Point Mutation; Polymorphism, Restriction Fragment Length; Proto-Oncogene Proteins c-ret; Sequence Analysis, DNA; Thyroid Gland; Thyroid Neoplasms; Vanilmandelic Acid | 2005 |